glp-1 refrigeration Injection Storage: Requirements & Guidelines – PlexusDx What does the science say

Survodutide, a glucagon/GLP-1 dual agonist, met its primary endpoint of histological improvement in MASH at 48 weeks and also demonstrated a statistically significant improvement in fibrosis, a secondary endpoint

Additionally, the study assessed weight and metabolic responses, finding that efinopegdutides tolerability was similar to that of semaglutide, although certain gastrointestinal side effects were more common

Most of these medications are injections, with dosing schedules that vary depending on the brand and specific treatment plan

If there is significant hanging skin, especially after prior obesity or very large weight loss, non-surgical tightening may improve skin quality and modest laxity, but it cannot remove large amounts of extra skin